Hepatocyte growth factor-activated NF-κB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines

Carcinogenesis

Volumn 25, Issue 11, 2004, Pages 2089-2100

  Tacchini, L ^a   De Ponti, C ^a   Matteucci, E ^a   Follis, R ^a   Desiderio, M A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; ORNITHINE DECARBOXYLASE; PROTEIN MCL 1; PROTEIN SUBUNIT; SCATTER FACTOR;

5' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GRADING; CANCER INVASION; CARCINOMA CELL; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; REPORTER GENE; RNA TRANSLATION; TRANSACTIVATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEPATOBLASTOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; LUCIFERASES; NF-KAPPA B; ORNITHINE DECARBOXYLASE; PLASMIDS; RNA, MESSENGER; TRANSFECTION;

EID: 8844286064     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh227     Document Type: Article

References (60)

1. Matteucci,E., Modora,S., Simone,M. and Desiderio,M.A. (2003) Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiency. Oncogene, 22, 4062-4073.
2. Jiang,W.G., Grimshaw,D., Lane,J., Martin,T.A., Abounader,R., Laterra,J., Mansel,R.E. and Abounder,R. (2001) A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clin. Cancer Res., 7, 2555-2562.
3. Pennacchietti,S., Michieli,P., Galluzzo,M., Mazzone,M., Giordano,S. and Comoglio,P.M. (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell, 3, 347-361.
4. Tacchini,L., Matteucci,E., De Ponti,C. and Desiderio,M.A. (2003) Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1. Exp. Cell Res., 290, 391-401.
5. Zarnegar,R. and Michalopoulos,G.K. (1995) The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol, 129, 1177-1180.
6. Danilkovitch-Miagkova,A. and Zbar,B. (2002) Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J. Clin. Invest., 109, 863-867.
7. Trusolino,L., Pugliese,L. and Comoglio,P.M. (1998) Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J., 12, 1267-1280.
8. Birchmeier,C., Birchmeier,W., Gherardi,E. and Vande Woude,G.F. (2003) Met, metastasis, motility and more. Nature Rev. Mol. Cell Biol., 4, 915-925.
9. Yao,Y., Jin,L., Fuchs,A., Joseph,A., Hastings,H.M., Goldberg,I.D. and Rosen,E.M. (1996) Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. Am. J. Pathol., 149, 1707-1717.
10. Tuck,A.B., Park,M., Sterns,E.E., Boag,A. and Elliott,B.E. (1996) Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol, 148, 225-232.
11. Beviglia,L., Matsumoto,K., Lin,C.S., Ziober,B.L. and Kramer,R.H. (1997) Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int. J. Cancer, 74, 301-309.
12. Funakoshi,H. and Nakamura,J. (2002) Hepatocyte growth factor: from diagnosis to clinical applications. Clin. Chim. Acta, 7986 1-23.
13. Tacchini,L., Dansi,P., Matteucci,E. and Desiderio,M.A. (2000) Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2. Exp. Cell Res., 256, 272-281.
14. Tacchini,L., Dansi,P., Matteucci,E. and Desiderio,M.A. (2001) Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis, 22, 1363-1371.
15. Karin,M., Cao,Y., Greten,F.R. and Li,Z.W. (2002) N-F-kappaB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer, 2, 301-310.
16. Helbig,G., Christopherson,K.W.,II, Bhat-Nakshatri,P., Kumar,S., Kishimoto,H., Miller,K.D., Broxmeyer,H.E. and Nakshatri,H. (2003) NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem., 278, 21631-21638.
17. Burstein,E. and Duckett,C.S. (2003) Dying for NF-kappaB? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr. Opin. Cell Biol., 15, 732-737.
18. Semenza,G.L. (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med., 8, S62-S67.
19. Blasi,F. and Carmeliet,P. (2002) uPAR: a versatile signalling orchestrator. Nature Rev. Mol. Cell Biol., 3, 932-943.
20. Wang,X., DeFrances,M.C., Dai,Y., Pediaditakis,P., Johnson,C., Bell,A., Michalopoulos,G.K. and Zarnegar,R. (2002) A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol. Cell, 9, 411-421.
21. Desiderio,M.A., Pogliaghi,G. and Dansi,P. (1998) Hepatocyte growth factor-induced expression of ornithine decarboxylase, c-met and c-myc is differently affected by protein kinase inhibitors in human hepatoma cells HepG2. Exp. Cell Res., 242, 401-409.
22. Dang,C.V. (1999) c-Myc target genes involved in cell growth, apoptosis and metabolism. Mol. Cell. Biol., 19, 1-11.
23. Coffino,P. (2001) Regulation of cellular polyamines by antizyme. Nature Rev. Mol. Cell Biol., 2, 188-194.
24. Katoh,O., Takahashi,T., Oguri,T., Kuramoto,K., Mihara,K., Kobayashi,M., Hirata,S. and Watanabe,H. (1998) Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res., 58, 5565-5569.
25. Platt,J.L. and Nath,K.A. (1998) Heme oxygenase: protective gene or Trojan horse. Nature Med., 4, 1364-1365.
26. Desiderio,M.A., Mattei,S., Biondi,G. and Colombo,M.P. (1993) Cytosolic and nuclear spermidine acetyltransferases in growing NIH 3T3 fibroblasts stimulated with serum or polyamines: relationship to polyamine-biosynthetic decarboxylases and histone acetyltransferase. Biochem. J., 293, 475-479.
27. Desiderio,M.A., Pogliaghi,G. and Dansi,P. (1998) Regulation of spermidine/spermine N1-acetyltransferase expression by cytokines and polyamines in human hepatocarcinoma cells (HepG2). J. Cell Physiol. 174, 125-134.
28. Thomas,T. and Thomas,T.J. (2001) Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol. Life Sci., 58, 244-258.
29. Desiderio,M.A., Tacchini,L., Anzon,E., Pogliaghi,G., Radice,L. and Bernelli-Zazzera,A. (1996) Effects of polyamine imbalance on the induction of stress genes in hepatocarcinoma cells exposed to heat shock. Hepatology, 24, 150-156.
30. Acs,G., Acs,P., Beckwith,S.M., Pitts,R.L., Clements,E., Wong,K. and Verma,A. (2001) Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res., 61, 3561-3565.
31. Akakura,N., Kobayashi,M., Horiuchi,J. et al. (2001) Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res., 61, 6548-6554.
32. Grassilli,E., Benatti,F., Dansi,P., Giammarioli,A.M., Malorni,W., Franceschi,C. and Desiderio,M.A. (1998) Inhibition of proteasome function prevents thymocyte apoptosis: involvement of ornithine decarboxylase. Biochem. Biophys. Res. Commun., 250, 293-297.
33. Toillon,R.A., Descamps,S., Adriaenssens,E., Ricort,J.M., Bernard,D., Boilly,B. and Le Bourhis,X. (2002) Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling. Exp. Cell Res., 275, 31-43.
34. Deng,J., Miller,S.A., Wang,H.Y., Xia,W., Wen,Y., Zhou,B.P., Li,Y., Lin,S.Y. and Hung,M.C. (2002) Beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell, 2, 323-334.
35. Das,R., Mahabeleshwar,G.H. and Kundu,G.C. (2003) Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J. Biol. Chem. 278, 28593-28606.
36. Lavrovsky,Y., Schwartzman,M.L. and Abraham,N.G. (1993) Novel regulatory sites of the human heme oxygenase-1 promoter region. Biochem. Biophys. Res. Commun., 196, 336-341.
37. Perkins,N.D. (2000) The Rel/NF-kappa B family: friend and foe. Trends Biochem. Sci., 25, 434-440.
38. Page,E.L., Robitaille,G.A., Pouyssegur,J. and Richard,D.E. (2002) Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem., 277, 48403-48409.
39. Kim,Y.J., Pan,H. and Verma,A.K. (1994) Non-AP-1 tumor promoter 12-O-tetradecanoylphorbol-13-acetate-responsive sequences in the human ornithine decarboxylase gene. Mol. Carcinog., 10, 169-179.
40. Martin,G.S. (2003) Cell signaling and cancer. Cancer Cell 4, 167-174.
41. Chen,F., Castranova,V. and Shi,X. (2001) New insights into the role of nuclear factor-kappaB in cell growth regulation. Am. J. Pathol., 159, 387-397.
42. Schmitz,M.L., Bacher,S. and Kracht,M. (2001) I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem. Sci., 26, 186-190.
43. Matteucci,E., Castoldi,R. and Desiderio,M.A. (2001) Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells. J. Cell Physiol., 186, 387-396.
44. Arakaki,N., Kajihara,T., Arakaki,R., Ohnishi,T., Kazi,J.A., Nakashima,H. and Daikuhara,Y. (1999) Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor. J. Biol. Chem., 274, 13541-13546.
45. Pozo-Guisado,E., Alvarez-Barrientos,A., Mulero-Navarro,S., Santiago-Josefat,B. and Fernandez-Salguero,P.M. (2002) The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol., 64, 1375-1386.
46. Bilton,R.L. and Booker,G.W. (2003) The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur. J. Biochem., 270 791-798.
47. Jung,Y., Isaacs,J.S., Lee,S., Trepel,J., Liu,Z.G. and Neckers,L. (2003) Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem. J., 370, 1011-1017.
48. Jung,Y.J., Isaacs,J.S., Lee,S., Trepel,J. and Neckers,L. (2003) IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J., 17, 2115-2117.
49. Huang,L.E. and Bunn,H.F. (2003) Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem., 278, 19575-19578.
50. Laughner,E., Taghavi,P., Chiles,K., Mahon,P.C. and Semenza,G.L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol., 21, 3995-4004.
51. Minet,E., Ernest,I., Michel,G., Roland,I., Remacle,J., Raes,M. and Michiels,C. (1999) HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5′UTR. Biochem. Biophys. Res. Commun., 261 534-540.
52. Sato,T., Hanada,M., Bodrug,S. et al. (1994) Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl Acad. Sci. USA, 91, 9238-9242.
53. Townsend,K.J., Trusty,J.L., Traupman,M.A., Eastman,A. and Craig,R.W. (1998) Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C. Oncogene, 17, 1223-1234.
54. Zhang,Y.W., Su,Y., Volpert,O.V. and Vande Woude,G.F. (2003) Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl Acad. Sci. USA, 100, 12718-12723.
55. Zhou,J., Schmid,T. and Brune,B. (2003) Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway. Mol. Biol. Cell, 14, 2216-2225.
56. Liu,X.M., Chapman,G.B., Wang,H. and Durante,W. (2002) Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation, 105, 79-84.
57. Panahian,N. and Maines,M.D. (2001) Site of injury-directed induction of heme oxygenase-1 and -2 in experimental spinal cord injury: differential functions in neuronal defense mechanisms? J. Neurochem. 76, 539-554.
58. Das,K.C. (2001) c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: role of thioredoxin in NF-kappaB activation. J. Biol. Chem., 276, 4662-4670.
59. Pena,A., Reddy,C.D., Wu,S., Hickok,N.J., Reddy,E.P., Yumet,G., Soprano,D.R. and Soprano,K.J. (1993) Regulation of human ornithine decarboxylase expression by the c-Myc. Max protein complex. J. Biol. Chem., 268, 27277-27285.
60. Yamamoto,Y. and Gaynor,R.B. (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest., 107, 135-142.